Transcultural Competence | Much More Than You Might Think

Transcultural Competence: Much More Than You Think  Jointly provided by Educational Review Systems and Ig National Society, Inc. (IgNS)  Target Audience This activity is intended for pharmacists and nurses.  Learning Objectives Upon completion of this activity,...

Ig Therapy Foundational Review

ACCREDITATION AND CREDIT DESIGNATION STATEMENT Pharmacist Credit Designation Educational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Participants of the session who complete...
Part 6. Secondary Immune Deficiencies from Biological Agents

Part 6. Secondary Immune Deficiencies from Biological Agents

Mark Ballow, MD Professor of PediatricsUniversity of South Florida Supported by Educational Grants from Pfizer and Takeda Speaker Additional Sessions Mark Ballow, MD Professor of PediatricsUniversity of South FloridaSupported by educational grants from: Pfizer, Inc...
Part 5. Immune Dysregulation

Part 5. Immune Dysregulation

Jennifer Leiding, MD Director, Multidisciplinary Immunology Services University of South Florida Supported by Educational Grants from Pfizer, Inc and Takeda Speaker Additional Sessions Jennifer Leiding, MD Director, Multidisciplinary Immunology ServicesUniversity of...
Part 4. Pulmonary Complications of Primary Immunodeficiency

Part 4. Pulmonary Complications of Primary Immunodeficiency

PJ Maglione, MD, PhD Assistant Professor Boston University School of Medicine Supported by Educational Grants from Pfizer and Takeda Speaker Additional Sessions PJ Maglione, MD, PhD Assistant Professor Boston University School of MedicineSupported by educational...
Part 3. The Complex Primary Immunodeficient Patient

Part 3. The Complex Primary Immunodeficient Patient

Richard Wasserman, MD, PhD Medical Director of Pediatric Allergy and ImmunologyMedical City Children’s Hospital Supported by Educational Grantsfrom Pfizer and Takeda Speaker Additional Sessions Richard Wasserman, MD, PhD Medical Director of Pediatric Allergy and...
Part 2. Autoinflammatory Disorders

Part 2. Autoinflammatory Disorders

Lori Broderick, MD, PhD Assistant Professor of Pediatrics University of California in San Diego Supported by Educational Grants from Pfizer and Takeda Speaker Additional Sessions Lori Broderick, MD, PhD Assistant Professor of Pediatrics University of California in San...

Transcultural Competence: Much More Than You Might Think

After the completion of this activity, the participant should be able to: Give two examples of ˜bias™. State how ˜ageism™ impacts clinicians. Describe three ways to provide safe and equitable care to the LGBTQ community. Speaker Amy E. Clarke, BSN, RN, IgCN® CE...

Multi-therapy Approaches to Management of Myasthenia Gravis

After the completion of this activity, the participant should be able to: Recognize the presentation of myasthenia gravis (MG) Appreciate the pathophysiology of MG Strategy the treatment approach to MG Speaker Charlene Hafer-Macko, MD CE Nursing 1 contact hour ACPE 1...

Primary Immune Deficiency in Geriatric Patients

After the completion of this activity, the participant should be able to: Understand that PID is not rare in the geriatric age group and maybe difficult to diagnose and be able to define the aging population Understand that aging normally causes deterioration and lose...

Controversies in CIDP: Targeting Remission vs. Stabilization

After the completion of this activity, the participant should be able to: Describe the natural history of CIDP Describe the mechanisms of action of immunoglobulin Discuss the role of immunoglobulin in the treatment of CIDP Discuss factors that may influence the...
Part 1. Primary Immunodeficiency: An Overview

Part 1. Primary Immunodeficiency: An Overview

Ken Paris, MD, MPH Program DirectorLSU Allergy/Immunology Fellowship Supported by Educational Grants from Pfizer and Takeda Speaker Additional Sessions Ken Paris, MD, MPH Program Director LSU Allergy/Immunology FellowshipSupported by educational grants from: Pfizer,...

Through the Rough Waters of Supply Interruptions

Recent shortages of immunoglobulin (Ig) products are impacting the access to care of patients across the US and worldwide. It is likely that your organization and your patients are affected by the limited availability of a specific product. What are some of the...

IVIg in the Treatment of Autoimmune Blistering Diseases

Intravenous immunoglobulin (IVIg) has been shown to be effective in the treatment for autoimmune blistering diseases like pemphigus vulgaris and bullous pemphigoid. While the precise mechanism of action is unknown, high-dose IVIg can be effective in achieving and...

The Intersection of Immune Deficiency and Autoimmunity

The connection between immune deficiency and autoimmunity is well recognized. This tangled web presents a wide variety of clinical presentations and outcomes. Advances in understanding of the molecular and cellular biology of these diseases have led to improvements in...

Solid Organ Transplantation

Ig therapy plays an important immunomodulatory role in incompatible organ transplantation with proven benefit for the desensitization of highly sensitized patients pretransplant to improve transplant rates and clinical outcomes. As the use of Ig therapy expands in...

Building a Culture of Safety: No Heroes Allowed

This program addresses the history and current state of preventable medical harm in the U.S. and the impact teamwork deficiencies on patient outcomes. The audience will be drawn into a conversation on the impact of our hierarchical structure on patient care. This...

Exercising with Peripheral Neuropathy

This session will focus on discussing the underlying causes of various neuropathies and understanding the goals of physical therapy, including improvement in function, flexibility and strength, balance, and reducing pain. Speakers Matt Hansen, DPT; Homespire, An...

Compliance and Risk Management

This session will focus on mitigation of risks in healthcare organizations through establishing specific compliance policies.  This session will describe risk reduction and practice improvement strategies, and various practice resources available.  Therapy adherence...

CVID: Overview of Genetic Causes and Diagnostic Testing

The session will describe the known genetic causes of CVID, focusing on recent patient and family case studies. The speakers will overview the clinical presentation of patients with common variable immunodeficiency (CVID), as well as other common causes of low Ig...

Needle Phobia, Pain, Anxiety, and Therapy Avoidance

Needle phobia has had an overwhelming rise in prevalence in the past two decades. Dr. Baxter’s session discusses evidence-based causes and consequences of needle fear and dives into multiple approaches to alleviate both needle pain and fear. In addition, the...

Bronchiectasis in Primary Immunodeficiency

Bronchiectasis is a complication observed with patients diagnosed chronic variable immunodeficiency.  This session will describe pathophysiology, presentation, and diagnostic markers of bronchiectasis.  This session will discuss management approaches and...

Ig Therapy for Antibody Mediated Diseases

This session will overview the role of antibodies in the pathogenesis of various disorders.  The various mechanisms of action of Ig therapy in antibody-mediated diseases, pharmacokinetics, and other factors that characterize clinical response will be discussed, as...

Ig Treatment Planning

Ig therapy treatment planning requires a systematic, standardized approach.  This session will focus on identifying the most important parameters of treatment planning including risk factor assessment, administration management, site of care consideration, patient...